Surgical therapy attenuates abdominal and extra-abdominal inflammation in experimental peritonitis

European Surgical Research

Volumn 38, Issue 2, 2006, Pages 76-82

  Van Till, J W O ^a   Lamme, B ^a   Van Esch, T J H ^a   Van Der Poll, T ^a   Van Gulik, T M ^a   Boermeester, M A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cecal ligation and puncture; Host response; Peritonitis; Source control

Indexed keywords

CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 6; MYELOPEROXIDASE;

ABDOMINAL CAVITY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CONTROLLED STUDY; GRANULOCYTE; INFLAMMATION; KERATINOCYTE; LAVAGE; LIGATION; LUNG; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PARAMETER; PERITONEAL CAVITY; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCTURE; SURGICAL TECHNIQUE; SURVIVAL;

ABDOMEN; ANIMALS; CECUM; CHEMOTAXIS, LEUKOCYTE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; IRRIGATION; KERATINOCYTES; LIGATION; LUNG; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PERITONITIS; PEROXIDASE; SPECIFIC PATHOGEN-FREE ORGANISMS; SURVIVAL RATE; WOUNDS, STAB;

EID: 33745033845     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092303     Document Type: Article

References (34)

1. Schein M: Surgical management of intra-abdominal infection: is there any evidence? Langenbeck Arch Surg 2002;387:1-7.
2. van Berge Henegouwen MI, van der Poll T, van Deventer SJ, Gouma DJ: Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications. Am J Surg 1998;175:311-316.
3. Lin, E, Calvano SE, Lowry SF: Inflammatory cytokines and cell response in surgery. Surgery 2000;127:117-126.
4. Haupt W, Zirngibl H, Klein P, Riese J, Hohenberger W: Reduced TNF-alpha and IL-6 production in patients who mount a preoperative acute phase response. Langenbeck Arch Surg 1998;383:71-74.
5. Kamei K, Nimura Y, Nagino M, Aono K, Nakashima I: Surgical stress reduces mortality from endotoxin shock. Langenbecks Arch Surg 2002;386:512-517.
6. Walley ER, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL: Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 1996;64:4733-4738.
7. Kohler J, Heumann D, Garotta G, LeRoy D, Bailat S, Barras C, Baumgartner JD, Glauser MP: IFN-gamma involvement in the severity of gram-negative infections in mice. J Immunol 1993;151:916-921.
8. Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D: Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 1999;67:6603-6610.
9. Martineau L, Shek PN: Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis. Crit Care Med 2000;28:788-794.
10. Dalrymple SA, Slattery R, Aud DM, Krishna M, Lucian LA, Murray R: Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun 1996;64:3231-3235.
11. Wellmer A, Gerber J, Ragheb J, Zysk G, Kunst T, Smirnov A, Bruck W, Nau R: Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun 2001;69:6881-6886.
12. Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B, Heidecke CD, Pfeffer K: Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 1998;66:2300-2309.
13. Rongione AJ, Kusske AM, Ashley SW, Reber HA, McFadden DW: Interleukin-10 prevents early cytokine release in severe intra-abdominal infection and sepsis. J Surg Res 1997;70:107-112.
14. van der Poll T, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer LL, Lowry SF: Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995;155:5397-5401.
15. Emmanuilidis K, Weighardt H, Maier S, Gerauer K, Fleischmann T, Zheng XX, Hancock WW, Holzmann B, Heidecke CD: Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J Immunol 2001;167:3919-3927.
16. Ajuebor MN, Das AM, Virag L, Flower RJ, Szabo C, Perretti M: Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999;162:1685-1691.
17. Sewnath ME, Olszyna DP, Birjmohun R, ten Kate FJW, Gouma DJ, van der Poll T: IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 2001;166:6323-6331.
18. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA: Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 1997;226:450-458.
19. Marshall JC, Maier RV, Jimenez M, Dellinger EP: Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004;32:S513-S526.
20. Schein M, Wittmann DH, Holzheimer R, Condon RE: Hypothesis: compartmentalization of cytokines in intraabdominal infection. Surgery 1996;119:694-700.
21. Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, van Rooijen N, van der Poll T: Alveolar macrophages have a protective anti-inflammatory role during murine pneumococcal pneumonia. Am J Resp Crit Care Med 2003;167:171-179.
22. Matsukawa A, Kaplan MH, Hogaboam CM, Lukacs NW, Kunkel SL: Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Ex Med 2001;193:679-688.
23. Riche FC, Cholley BP, Panis YH, Laisne MJ, Briard CG, Graulet AM, Gueris JL, Valleur PD: Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med 2000;28:433-437.
24. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MRB: Interleukin-6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994;81:1306-1308.
25. Wang Q, Fang CH, Hasselgren PO: Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol 2001;281:R1013-R1023.
26. Zemel D, Koomen GCM, Hart AAM, Tenberge IJM, Struijk DG, Krediet RT: Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993;122:686-696.
27. 7 Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
28. Call DR, Nemzek JA, Ebong SJ, Bolgos GL, Newcomb DE, Remick DG: Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment. Am J Pathol 2001;158:715-721.
29. Godshall CJ, Scott MJ, Peyton JC, Gardner SA, Cheadle WG: Genetic background determines susceptibility during murine septic peritonitis. J Surg Res 2002;102:45-49.
30. Wickel DJ, Cheadle WG, Mercer-Jones MA, Garrison RN: Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection. Ann Surg 1997;225:744-753.
31. Ferrer TJ, Webb JW, Wallace BH, Bridges CD, Palmer HE, Robertson RD, Cone JB: Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS). J Surg Res 1998;77:157-164.
32. Latifi SQ, O'Riordan MA, Levine AD: Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 2002;70:4441-4446.
33. Nathens AB, Rotstein OD, Marshall JC: Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg 1998;22:158-163.
34. Mulier S, Penninckx F, Verwaest C, Filez L, Aerts R, Fieuws S, Lauwers P: Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg 2003;27:379-384.